To lower your risk of insomnia, our read is that intentionally shortening sleep opportunity can be a well-supported strategy.
Our read is that intentionally shortening sleep opportunity is often employed in insomnia treatment to enhance sleep efficiency. This approach aims to compel the brain to prioritize sleep, thereby improving its efficiency. While elevated sympathetic nervous system activity and cortisol spikes are observed in individuals with insomnia, these endocrine challenges often necessitate behavioral therapy.
Sleep opportunity is often intentionally shortened to drive up sleep efficiency, forcing the brain to prioritize sleep and increase efficiency.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
High sympathetic and glucocorticoid output, often present in insomnia, are difficult endocrine problems to treat and frequently require behavioral therapy.
New evidence describing alternative, non-behavioral methods for treating high sympathetic and glucocorticoid output, or new insights into the direct causes of insomnia beyond sleep opportunity, would change the verdict.
Mechanistic and trial evidence converge on a real, replicable effect.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.